The economic consequences of Alzheimer's disease in the context of new drug developments

International Journal of Geriatric Psychiatry

Volumn 13, Issue 8, 1998, Pages 531-543

  Knapp, Martin ^a   Wilkinson, David ^b   Wigglesworth, Rachel ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b Western Community Hospital   (United Kingdom)

Author keywords

Alzheimer's disease; Cholinesterase inhibitors; Economics

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; SABELUZOLE; TACRINE;

ALZHEIMER DISEASE; ARTICLE; COST CONTROL; DAILY LIFE ACTIVITY; DIARRHEA; DRUG EFFICACY; GERONTOPSYCHIATRY; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; LICENSING; NAUSEA; SYMPTOM; VOMITING;

AGED; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COGNITION; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DRUG THERAPY; FORECASTING; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS;

EID: 0031688768     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1166(199808)13:8<531::AID-GPS815>3.0.CO;2-M     Document Type: Article

References (98)

1. Association of Directors of Social Services (1994) Towards Community Care: ADSS Review of the First Year. Association of Directors of Social Services, London.
2. Audit Commission (1997) The Coming of Age. HMSO, London.
3. Ballard, C. G., Eastwood, C., Gahir, M. and Wilcock, G. (1996) A follow up study of depression in the carers of dementia sufferers. Brit. Med. J. 312, 947.
4. Banerjee, A., Brogan, S., Burns, A., Carpenter, I., Corina, R., Fulop, N., Matt, E., O'Driscoll, B., Perren, J. and Wade, A. (1997) The impact of Alzheimer's disease on the health service: Setting new standards in the NHS. Consensus Report, Macmillan Magazines.
5. Banerjee, S. and McDonald, A. J. D. (1996) Mental disorder in an elderly home care population: Associations with health and social service use. Brit. J. Psychiat. 168, 750-756.
6. Bass, D. M., Noelker, L. S. and Rechlin, L. R. (1996) The moderating influence of service use on negative caregiving consequences. J. Gerontol. B. Psychol. Sci. Soc. Sci. 51(3), S121-S131.
7. Baumgarten, M. (1989) The health of persons giving care to demented elderly: A critical review of the literature. J. Clin. Epidemiol. 45, 1137-1148.
8. Beck, B. (1996) The economics of ageing. Economist, 11 January, Supplement.
9. Beecham, J., Cambridge, P., Hallam, A. and Knapp, M. R. J. (1994) The costs of domus care. In The Domus Report: Long-Term Care for Older People with Dementia (E. Murphy, J. Lindesay and R. Dean, (Eds). Sainsbury Centre for Mental Health, London.
10. Beske, F. and Kunczik, T. (1993) Fruhzeitige Therpie kann Milliarden sparen. Der Kassenarzt, 3-6.
11. Blanco, M. (1995) Consideraciones sobre el demente y su cuidador en la enfermedad de Alzheimer. Gerontologia 11, 53-56.
12. Boersma, F., Eefsting, J. A., Brink, W. van den, and Tilburg, W. van (1997) Care services for dementia patients: Predictors for service utilization. Int. J. Geriatr. Psychiat. 12, 1119-1126.
13. Bonneux, L. (1996) Personal communication.
14. Brodaty, H., McGilchrist, C., Harris, L. and Peters, K. E. (1993) Time until institutionalization and death in patients with dementia. Arch. Neurol. 50, 643-650.
15. Busschbach, J. V., Brouwer, V., Van Der Donk, A., Passchier, J. and Rutten, F. (1998) An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer's disease. Pharmacoeconomics 13(1), 21-34.
16. Cabellero Garcia, J. C., Garay Lillo, J., Guijarro Garcia, J. L. and Lozano Fernandez, R. (1993) Consideraciones sobre la enfermedad de Alzheimer: Epidemiologia, diagnostico, asistencia y tratomiento. Geriatrica 9, 37-47.
17. Canadian Study of Health and Aging (1994) Patterns of caring for people with dementia in Canada. Can. J. Aging 13, 470-487.
18. Cavallo, M. C. and Fattore, G. (1994) Il costo sociale della malattia di Alzheimer: Metodologia e risultati di una indagine preliminare. Mecosan 10, 12-23.
19. Cavallo, M. C. and Fattore, G. (1997) The economic and social burden of Alzheimer's disease on families in the Lombardy region, Italy. Alz. Dis. Assoc. Disord., in press.
20. Clipp, E. C. and George, L. K. (1990) Psychotropic drug use among caregivers of patients with dementia. J. Am. Geriatr. Soc. 38, 227-235.
21. Clipp, E. and Moore, M. (1995) Caregiver time use: An outcome measure in clinical trial research in Alzheimer's Disease. Clin. Pharmacol. Ther. 58, 228-236.
22. Coleman, B. J. (1995) European models of long term care in the home and the community. Int. J. Health Serv. 5, 455-474.
23. Darton, R. A. and Knapp, M. R. J. (1984) The cost of residential care for the elderly: The effects of dependency, design and social environment. Ageing Soc. 4, 157-183.
24. Darton, R. A. and Wright, K. (1992) Residential and nursing homes for elderly people: One sector or two? In Social Policy and Elderly People. The Role of Community Care (F. Laczko and C. R. Victor, Eds). Avebury, Aldershot.
25. Davies, B. P. (1992) Care Management, Equity and Efficiency: The International Experience. PSSRU, University of Kent at Canterbury.
26. Davies, B. P. and Challis, D. J. (1986) Matching Resources to Needs in Community Care. Gower, Aldershot.
27. Davies, B. P. and Knapp, M. R. J. (1981) Old People's Homes and the Production of Welfare. Routledge & Kegan Paul, London.
28. Davis, K. L., Thal, L. J., Gamzu, E. R. et al. (1992) A double blind placebo controlled multicentre study of tacrine for Alzheimer's disease. New Engl. J. Med. 327, 1253-1259.
29. Donaldson, C., Tarrier, N. and Burns, A. (1997) The impact of the symptoms of dementia on caregivers. Brit. J. Psychiat. 170, 62-68.
30. Ernst, R. L. and Hay, J. W. (1994) The US economic and social costs of Alzheimer's disease revisited. Am. J. Pub. Health 84, 1261-1264.
31. Ernst, R. L., Hay, J. W., Fenn, C., Tinklenberg, J. and Yesavage, J. A. (1997) Cognitive function and the costs of Alzheimer's disease. An exploratory study. Arch. Neurol. 54(6), 687-693.
32. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1995) Mini Mental State. A practical method for grading the cognitive state of subjects for the clinician. J. Psychiat. Res. 12, 189-198.
33. Fratiglioni, L., Forsell, Y., Torres, H. A. and Winblad, B. (1994) Severity of dementia and institutionalisation in the elderly: Prevalence data from an urban area in Sweden. Neuroepidemiology 13, 79-88.
34. Friedhoff, L. T. and Rogers, S. L. (1997) Donepezil lengthens time to loss of activities of daily living in patients with mild or moderate Alzheimer's disease -results of a preliminary evaluation. Neurology 48(3), 02-026.
35. Fries, B. E., Mehr, D. R., Schneider, D., Foley, W. J. and Burke, R. (1993) Mental dysfunction and resource use in nursing homes. Med. Care 10, 898-920.
36. Gray, A. M. and Fenn, P. (1993) Alzheimer's disease: The burden of illness in England. Health Trends 25, 31-37.
37. Gray, A. M. (1995) The economic impact of Alzheimer's disease. Rev. Contemp. Pharmacother. 6, 329-334.
38. Guillemard, A-M. J., Alber, J. and Walker, A. (1993) Older People in Europe: Social and Economic Policies. Commission of the European Communities, Brussels.
39. Harrow et al. (1995) How costly is it to care for disabled elder in a community setting? Gerontologist 35(6), 803-813.
40. Hasegawa, K., Homma, A. and Imai, Y. (1986) An epidemiological study of age-related dementia in the community. Int. J. Geriatr. Psychiat. 15, 122-129.
41. Hay, J. W., Sano, M. and Whitehouse, B. (1997) The costs and social burden of Alzheimer's disease: What can and should be done. Alz. Dis. Assoc. Disord. 11, 181-183.
42. Henke, C. J. and Burchmore, M. J. (1997) The economic impact of tacrine in the treatment of Alzheimer's disease. Clin. Therapeut. 19, 330-345.
43. Hu, T. W., Huang, L. F. and Cartwright, W. S. (1986) Evaluation of the costs of caring for the senile demented elderly: A pilot study. Gerontologist 26, 158-163.
44. Huang, L. F., Cartwright, W. S. and Hu, T. W. (1988) The economic cost of senile dementia in the United States, 1985. Pub. Health Rep. 103, 3-7.
45. Jones, D. A. and Peters, J. (1992) Caring for elderly dependants: Effects on the carer's quality of life. Age Ageing 21, 421-428.
46. Kavanagh, S. M. and Knapp, M. R. J. (1995) Market rationales, rationing and rationality: Mental health care reform in the UK. Health Affairs 14, 260-268.
47. Kavanagh, S. M., Schneider, J., Knapp, M. R. J., Beecham, J. K. and Netten, A. (1995) Elderly people with dementia: Costs, effectiveness and balance of care. In The Economic Evaluation of Mental Health Care. (M. R. J. Knapp, Ed.). Arena, Aldershot.
48. Knapp, M. J., Knopman, D. S., Solomon, P. R., Pendlebury, w. S., Davis, C. S. and Gracon, S. I. (1994a) A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. J. Am. Med. Assoc. 271, 985-991.
49. Knapp, M. R. J., Cambridge, P., Thomason, C., Beecham, J. K., Allen, C. and Darton, R. A. (1994b) Residential care as an alternative to long-stay hospital: A cost-effectiveness evaluation of two pilot projects. Int. J. Geriatr. Psychiat. 9, 297-304.
50. Knapp, M. R. J., Pinner, J. and Topan, C. (1995) Economic evaluation and dementia. In Developments in Dementia and Functional Disorders in the Elderly (R. Levy and R. Howard, Eds). Wrightson Biomedical, Petersfield.
51. Knopman, D. (1995) Tacrine for Alzheimer's disease. Pharmacoeconomics, 275-279.
52. Knopman, D., Schneider, L., Davis, K., Talwalker, S., Smith, F., Hoover, T., Gracon, S. and the Tacrine Study Group (1996) Long-term tacrine treatment: Effects on nursing home placement and mortality. Neurology, 166-177.
53. Le Bars, P. L., Katz, M. M., Berman, N., Itil, T. M., Freedman, A. M. and Schatzherg, A. F. (1997) A controlled double-blind, randomised trial of an extract of Ginkgo Biloba for dementia. J. Am. Med. Assoc. 278, 1327-1332.
54. Levin, E., Moriaty, J. and Gorbach, P. (1994) Better for the Break. National Institute for Social Work, HMSO, London.
55. Levin, E., Sinclair, I. and Gorbach, P. (1989) Families, Services and Confusion in Old Age. Gower, Aldershot.
56. Lieberman, M. A. and Fisher, L. (1995) The impact of chronic illness on the health and well-being of family members. Gerontologist 35, 94-102.
57. Livingston, G., Manela, M. and Katona, C. (1997) Cost of community care for older people. Brit. J. Psychiat. 171, 56-69.
58. Lovestone, S. (1997) Muscarinic therapies in Alzheimer's disease from palliative treatments to disease modification. Int. J. Psychiat. Clin. Pract. 1, 15-20.
59. Lubeck, D. P., Mazonson, P. D. and Bowe, T. (1994) Potential effect of tacrine on expenditures for Alzheimer's disease Med. Interface, 130-138.
60. Maas, M. (1988) Management of patients with Alzheimer's disease in long-term care facilities. Nurs. Clin. N. Am. 23, 57-58.
61. Max, W. (1993) The economic impact of Alzheimer's disease. Neurology 43, S6-S10.
62. Melzer, D., Ely, M. and Brayne, C. (1997) Cognitive impairment in elderly people: Population based estimate of the future in England, Scotland and Wales. Brit. Med. J. 315, 462.
63. Melzer, D., Hopkins, S., Pencheon, D., Brayne, C. and Williams, R. (1994) Dementia. In Health Care Needs Assessment (A. Stevens and J. Raftery, Eds). Radcliffe Medical Press, Oxford.
64. Murphy, E., Lindesay, J. and Dean, R. (1994) The Domus Project: Long-Term Care for Older People with Dementia. Sainsbury Centre for Mental Health, London.
65. National Health Service Executive (1996) Burdens of Disease. NHSE, Leeds.
66. Netten, A. and Dennett, J. (1997) Unit Costs of Health and Social Care 1997. PSSRU, University of Kent at Canterbury.
67. Nuttall, S. R., Blackwood, R. J. L., Bussell, B. M. H. et al. (1993) Financing long-term care in Great Britain. J. Inst. Actuaries 121, 1-68.
68. O'Brien, B., Goeree, R., Hux, M., Iskedjian, M., Blackhouse, G., Gauthier, S. and Gagnon, M. (1997) Economic evaluation of donepezil for Alzheimer's disease in Canada. Abstract accepted for Am. Soc. Clin. Pharmacol. Therapeut.
69. O'Connor et al. (1989) Distribution of services to elderly demented people living in the community. Int. J. Geriatr. Psychiat. 4, 339-344.
70. OECD (1996) Caring for Frail Elderly People. Social Policy Studies, 19. OECD, Paris.
71. Opit, L. and Pahl, J. (1993) Institutional care for elderly people: Can we predict admissions? Res. Policy Planning 10, 2-5.
72. Osterweil, D., Martin, M. and Syndulko, K. (1995) Predictors of skilled nursing placement in a multi-level long-term care facility. J. Am. Geriatr. Soc. 43, 108-112.
73. Østbye, T. and Crosse, E. (1994) Net economic costs of dementia. Can. Med. Assoc. J. 151, 10.
74. Philp, I., McKee, K. J., Meldrum, P., Ballinger, B. R., Golhooly, M. L. M., Gordon, D. S., Mutch, W. J. and Whittick, J. E. (1995) Community care for demented and non-demented elderly people: A comparison study of financial burden, service use, and unmet needs in family supporters. Brit. Med. J. 310, 1503-1506.
75. Raskind, M. A., Sadowsky, C. H., Sigmund, W. R., Beitler, P. J. and Auster, S. B. (1997) Effect of Tacrine on language, praxis, and noncognitive behavioural problems in Alzheimer's disease. Arch. Neurol. 54(7), 836-840.
76. Rice, D., Fox, P., Hauck, W. et al. (1991) The burden of caring for Alzheimer's disease patients. National Center for Health Statistics. Proceedings of the 1991 Public Health Conference on Records and Statistics. US Department of Health and Human Services, Washington, DC, pp. 119-124.
77. Rice, D., Fox, P. J., Max, W. et al. (1993) The economic burden of Alzheimer's disease care. Health Affairs 12(2), 164-176.
78. Ritchie, K., Colvez, A., Ankri, J. et al. (1992) The evaluation of long-term care for the dementing elderly: A collective study of hospital and collective non-medical care in France. Int. J. Geriatr. Psychiat. 7, 549-557.
79. Ritchie, K. and Ledesert, B. (1992) The families of the institutionalised dementing elderly. A preliminary study of stress in a French caregiver population. Int. J. Geriatr. Psychiat. 7, 5-14.
80. Rocca, W. A., Hofman, A., Brayne, C. et al. (1991) Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980-1990 prevalence findings. Ann. Neurol. 30, 381-390.
81. Rogers, S. L., Friedhoff, L. T. and the Donepezil Study Group (1996) The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia 7, 293-303.
82. Rosen, W. G., Mohs, R. C. and Davis, K. L. (1984) A new rating scale for Alzheimer's disease. Am. J. Psychiat. 141, 1356-1364.
83. Rosser, M. (1988) In Handbook of Psychopharmacology, Vol. 20 (L. Iversen, S. Iversen and S. Snyder, Eds), pp. 107-130.
84. Ryan, D. H. (1994) Misdiagnosis in dementia: Comparisons of diagnostic error rate and range of hospital investigation according to medical specialty. Int. J. Geriatr. Psychiat. 9, 141-147.
85. Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., Schneider, L. S. and Thai, L. J. (1997) A controlled trial of selegiline, alpha-tocoplerol, or both as treatments for Alzheimer's disease. New Engl. J. Med. 336(17), 1216-1222.
86. Schneider, J., Kavanagh, S. M., Knapp, M. R. J., Beecham, J. and Netten, A. (1993) Elderly people with advanced cognitive impairment in England: Resource use and costs. Ageing Soc. 13, 27-50.
87. Schulz, R. and Brenner, G. (1977) Relocation of the aged: A review and theoretical analysis. J. Gerontol. 32, 323-333.
88. Severson, M. A., Smith, G. E., Tangalos, E. G. et al. (1994) Patterns and predictors of institutionalization in community-based dementia patients. J. Am. Geriatr. Soc. 42, 181-185.
89. Souêtre, E. J., Qing, W., Vigoureux, I., Dartigues, J. F., Lozet, H., Lacomblez, L. and Derouesne, C. (1995) Economic analysis of Alzheimer's disease in out-patients: Impact of symptom severity. Int. Psychogeriat. 7, 115-122.
90. Stommel, M., Collins, C. E. and Given, B. A. (1994) The costs of family contributions to the care of persons with dementia. Gerontologist 34, 199-205.
91. Torian, L., Davidson, E., Fulop, G., Sell, L. and Fillit, H. (1992) The effect of dementia on acute care in a geriatric medical unit. Int. Psychogeriat. 4, 231-239.
92. Trabucchi, M., Govoni, S. and Bianchetti, A. (1995) Socio-economic aspects of Alzheimer's disease. In Alzheimer's Disease: Therapeutic Strategies (E. Giacobini and R. Becker, Eds). Bosley, Birkhauser, pp. 459-463.
93. Warburton, R. W. (1994) Home and away: A review of recent research evidence to explain why some elderly people enter residential care homes while others stay at home. Department of Health, London.
94. Weinberger, M., Gold, D. T., Divine, G. W., Cowper, P. A., Hodgson, L. G., Schreiner, P. J. and Goerge, L. K. (1993) Expenditures in caring for patients with dementia who live at home. Am. J. Pub. Health 83, 338-341.
95. Welch, H. G., Walsh, J. S. and Larson, E. B. (1992) The cost of institutional care in Alzheimer's disease: Nursing home and hospital use in a prospective cohort. J. Am. Geriatr. Soc. 40, 221-224.
96. Wimo, A., Krakau, I., Mattsson, B. and Nelvig, A. (1994) The impact of cognitive decline and workload on the costs of dementia care. Int. J. Geriatr. Psychiat. 6, 21-29.
97. Wimo, A., Mattson, B., Krakau, I., Eriksson, T., Nelving, A. and Karisson, G. (1995) Cost-utility analysis of group living in dementia care. Int. J. Technol. Assess. Health Care. 11, 49-65.
98. World Bank (1993).